PROTAGENIC THERAPEUTICS INC (PTIX)

US74365N2027 - Common Stock

0.608  +0.01 (+2.17%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

PROTAGENIC THERAPEUTICS INC

NASDAQ:PTIX (11/21/2024, 4:30:01 PM)

0.608

+0.01 (+2.17%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-59.62%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap4.13M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

PTIX Daily chart

Company Profile

Protagenic Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in New York City, New York and currently employs 1 full-time employees. Its lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide (TCAP), an endogenous brain signaling peptide that can dampen overactive stress responses. Its lead compound is a 41-amino-acid synthetic peptide, which focuses on treating various neuro-psychiatric conditions, including depression, anxiety, and post-traumatic stress disorder (PTSD). The company operates with a novel mechanism, mirroring the active part of the natural brain hormone TCAP, thereby reducing circulating cortisol levels. In addition, it has a portfolio of earlier stage neuropeptides targeting the TCAP pathway that are in preclinical evaluation. The initial dosage form is intended as a subcutaneous injection but is also amenable to other routes of administration including sublingually or intra-nasally.

Company Info

PROTAGENIC THERAPEUTICS INC

149 Fifth Avenue, Suite 500

New York City NEW YORK 10010

P: 12129948200

CEO: Garo H. Armen

Employees: 1

Website: https://protagenic.com/

PTIX News

ChartMill News Image9 days ago - ChartmillWhich stocks are gapping on Tuesday?

The market is filled with gapping stocks in Tuesday's session. Let's discover which stocks are showing gap-ups and gap-downs.

News Image17 days ago - ACCESSWIREProtagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million
News Image3 months ago - InvestorPlacePTIX Stock Earnings: Protagenic Therapeutics Reported Results for Q2 2024

Protagenic Therapeutics just reported results for the second quarter of 2024.

News Image3 months ago - BusinessInsiderPTIX Stock Earnings: Protagenic Therapeutics Reported Results for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Protagenic Therapeutics (NASDAQ:PTIX) just reported results for the second quar...

News Image5 months ago - BusinessInsiderPTIX Stock Earnings: Protagenic Therapeutics Reported Results for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Protagenic Therapeutics (NASDAQ:PTIX) just reported results for the first quart...

News Image5 months ago - InvestorPlacePTIX Stock Earnings: Protagenic Therapeutics Reported Results for Q1 2024

Protagenic Therapeutics just reported results for the first quarter of 2024.

PTIX Twits

Here you can normally see the latest stock twits on PTIX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example